Technical Data
Inhibitory Mold Agar (Powder)
Microbiological Grade
Storage RT/4C    Shipping RT
Components shown as g/L
Ferrous Sulfate0.04
Magnesium Sulfate0.8
Manganese Sulfate0.16
Peptic Digest of Animal Tissue2.0
Sodium Chloride0.04
Sodium Phosphate, Dibasic2.0
Pancreatic Digest of Casein3.0
Yeast Extract 5.0
Total: 36.2g/L
General purpose medium for isolation of pathogenic fungi.

Pathogenic fungi constitute a very small group among the vast number of organisms that belong to the Kingdom Fungi. Fungi with the potential to cause human diseases belong to the genera Aspergillus, Candida, Cryptococcus, Histoplasma and Pneumocystis. Members of pathogenic fungi groups are scattered throughout four taxonomic classes based on their methods of reproduction viz. Zygomycetes, Basidiomycetes, Ascomycetes and Deuteromycetes (Fungi Imperfecti). To confirm the existence and nature of infection by fungi and yeasts, direct methods are more important than indirect methods; identification of the organisms is much more useful than demonstrating the humoral and cellular responses of the host. Inhibitory Mould Agar formulated as per Ulrich is used as a general-purpose medium for the selective isolation and cultivation of pathogenic fungi.

Directions per Liter: Dissolve 36.2grams in 800-900ml of ddH2O stirring gently with heating until completely solubilized. Adjust pH of the medium to the desired level. Add additional water to bring the solution to1L. Dispense into appropriate containers, loosen caps and autoclave for 15 minutes at 121C (15psi).

Storage and Stability: Store powdered media at RT. Opened bottles should be capped tightly and kept in a dark, low humidity environment. Prepared media should be kept at 4C and used within a short period of time.

Appearance: Light tan to yellow homogeneous, free-flowing powder

Solubility: Amber, clear to slightly opalescent after autoclaving

pH: As Reported

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

1.Cruikshank R., Marmion B. P., Duguid J. P., Swain R.H.A., (Eds.), Medical Microbiology, 12th Edition, Vol. II, Churchill Livingstone 2.Frey D., Oldfield R. J., Bridger R. C., A Colour Atlas of Pathogenic Fungi, Wolfe Medical Publications, London. 3.Ulrich J. A., 1956, Bact. Proc., S.A.B., M75: 87.